SavedAdd your journal

Journals / Journal of Neurological Sciences (Turkish) / 2013 / Cilt: 30 - Sayı: 2

Santral Sinir Sisteminin Primer Yaygın Büyük B Hücreli Lenfomasının Yönetimi: Klinik Çalışma

Management of Primary Diffuse Large B-cell Lymphoma of The Central Nervous System: Clinical Study

Askin Esen HASTURK
Mehmet BASMACI
Tulu AYATA
Pages
469–476
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The objectiveof this study is to assess 9 patients who presented with PCNSL, retrospectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary Central Nervous System Lymphomas (PCNSL) are defined as the extra nodal non- Hodgkin lymphomas which may typically be localized in brain, eyes, spinal cord and CSFwithout arising from a focus site, and which are uncommon and nonHodgkin types.
📊
Key Findings & Data:Theprevalence of PCNSL has been reported to have increased pronouncedly for the last 1530years.
💡
Conclusion & Impact:The objectiveof this study is to assess 9 patients who presented with PCNSL, retrospectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary Central Nervous System Lymphomas (PCNSL) are defined as the extra nodal non- Hodgkin lymphomas which may typically be localized in brain, eyes, spinal cord and CSFwithout arising from a focus site, and which are uncommon and nonHodgkin types. Theprevalence of PCNSL has been reported to have increased pronouncedly for the last 1530years. The reason of this increase for the PCNSL among other primary brain tumors isconsidered to be associated with the improvements in the diagnostic methods. The objectiveof this study is to assess 9 patients who presented with PCNSL, retrospectively.

Özet

Primer santral sinir sistem lenfomaları (PSSSL), vücudun herhangi bir yerinde primer birodak olmaksızın, tipik olarak beyin, göz, spinal kord ve beyin omurilik sıvısına lokalize olanekstranodal non-Hodgkin lenfomalar olarak tanımlanmaktadır. Son 15-30 yıl içerisindePSSSL tanısı dramatik olarak yükselmiştir. Diğer birincil beyin tümörleri arasında PSSSL içinartışın nedeni, tanı yöntemlerinin gelişmesi ile bağlantılıdır. Bu çalışmanın amacı, geriyedönük olarak, PSSSL ile başvuran 9 hasta değerlendirmektir.

🔖

Cite This Article

HASTURK, A. E., BASMACI, M., AYATA, T. (2022). Santral Sinir Sisteminin Primer Yaygın Büyük B Hücreli Lenfomasının Yönetimi: Klinik Çalışma. Journal of Neurological Sciences (Turkish), Cilt: 30 - Sayı: 2, 469–476. https://ajindex.com/articles/565146

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Baraj as RF Jr, Rubenstein JL, Chang JS, Hwang J, Cha S. Diff usion-weighted MR imaging derived apparent diff usion coeff icient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2010; 31: 60- 66
  2. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med 2008; 132: 1830-1834
  3. Carrabba MG, Reni M, Foppoli M, et al. Treatment approaches f or primary CNS lymphomas. Expert Opin Pharmacother 2010; 11: 1263-1276
  4. Cavaliere R, Petroni G, Lopes MB, Schiff D. International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system posttransplantation lymphoprolif erative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010; 15;116: 863-870
  5. Chimienti E, Spina M, Vaccher E, Tirelli U. Management of immunocompetent patients with primary central nervous system lymphoma. Clin Lymphoma Myeloma 2009; 9: 353-364
  6. Commins DL. Pathology of primary central nervous system lymphoma. Neurosurg Focus 2006; 21: E2
  7. Corn BW, Marcus SM, Topham A, Hauck W, Curan WJ JR. Will primary central nervous system lymphoma be the most f requent brain tumor diagnosed in the year 2000. Cancer 1997; 79: 2409- 2413
  8. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodef iciency syndrome. AIDS/ Cancer Study Group. J Natal Cancer Inst 1996; 88: 675–679
  9. Deangelis LM, Hormigo A. Treatment of primary central nervous system lymphoma. Semin Oncol 2004; 31: 684-692
  10. Ferreri AJ, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: Lessons f rom prospective trials. Ann Oncol 2000; 11: 927-937 11. Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol 2010; 67: 291-297
  11. Go JL, Lee SC, Kim EP. Imaging of primary central nervous system lymphoma. Neurosurg Focus 2006; 21: E4
  12. Grant JW, Isaacson PG. Primary central nervous system lymphoma. Brain Pathol 1992; 2: 97-109
  13. Hatipoglu HG, Ergungor MF, Daglioglu E, Uzum N, Ciliz D, Yuksel E. Primary Central Nervous System Lymphoma: Diff usion Weighted Imaging and Spectroscopy J Neurl Sci Turk 2010;27:98-103
  14. Hattab EM, Martin SE, Al-Khatib SM, et al. Most primary central nervous system diff use large Bcell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 case